First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC

NCT00456261 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Pemetrexed
DRUG: Gemcitabine
DRUG: Bevacizumab
DRUG: Carboplatin

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]